Is a complete TLSA research report available?

No complete published report is available for Tiziana Life Sciences Ltd (TLSA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Tiziana Life Sciences Ltd (TLSA)

NASDAQ: TLSA · USD

$0.97

+0.01 (+1.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TLSA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	125.4M
Net income (ttm)	-18.4M
EPS (ttm)	-$0.16
Shares out	129.3M
Volume	15,314.272
Beta	0.44

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -18.4M
EPS (ttm): -$0.16
Market cap: 125.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TLSA indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001723069
Company name	Tiziana Life Sciences Ltd
Country	United Kingdom
Country code	US
Cusip	G88912103
Employees	10
Employees Change	1%
Employees Change Percent	11.11
Enterprise value	$121.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-03-24
Isin	BMG889121031
Last refreshed	2026-07-31
Market cap	$125.4M
Market cap category	Micro-Cap
Price	$0.97
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	TLSA
Website	https://www.tizianalifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.69%
FCF yield	-10.26%
P/B ratio	2,412.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-18.4M
Net Income Growth Years	0%
Profit Per Employee	$-1.8M
ROA	-116
Roa5y	-62.22
ROCE	-7,388.8
ROE	-924.3
Roe5y	-282.3
ROIC	-580.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.53%
Cagr3y	14.86%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$11.5M
Cash	$4M
Current Assets	$8.6M
Current Liabilities	$11.2M
Debt	$456,000
Debt Equity	$8.77
Equity	$52,000
Interest Coverage	-1,174
Liabilities	$11.4M
Long Term Assets	$2.9M
Long Term Liabilities	$234,000
Net Cash	$3.6M
Net Cash By Market Cap	$2.83
Net Cash Growth	279.7%
Net Debt Equity	$-68.35
Tangible Book Value	$52,000
Tangible Book Value Per Share	$0
WACC	6.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.76
Net Working Capital	$-6.4M
Quick ratio	0.72
Working Capital	$-2.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.88%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50.51%
200-day SMA	1.44
3Y total return	51.54%
50-day SMA	1.2
50-day SMA vs 200-day SMA	50under200
All Time High	2.6
All Time High Change	-62.69%
All Time High Date	2025-08-01
All Time Low	0.41
All Time Low Change	136.59%
All Time Low Date	2024-04-15
ATR	0.11
Beta	0.44
Beta1y	0.13
Beta2y	-0.16
Ch YTD	-34.9
High	1.01
High52	2.6
High52 Date	2025-08-01
High52ch	-62.69%
Low	0.95
Low52	0.87
Low52 Date	2026-07-24
Low52ch	11.97%
Ma50ch	-19.17%
Premarket Change Percent	0.13
Premarket Price	$0.96
Premarket Volume	464
Price vs 200-day SMA	-32.78%
RSI	40.55
RSI Monthly	43.53
RSI Weekly	38.81
Sharpe ratio	-0.51x
Sortino ratio	-0.69
Total Return	-10.88%
Tr YTD	-34.9
Tr1m	-21.14%
Tr1w	-4.9%
Tr3m	-23.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.13
Operating Income	$-21.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68,512,789%
Float Percent	52.98%
Net Borrowing	-196,000
Shares Insiders	47.02%
Shares Institutions	37.39%
Shares Out	129,307,401
Shares Qo Q	2.49%
Shares Yo Y	10.88%
Short Ratio	5.61
Short Shares	3.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.4M
Adjusted OCF	-17,389,000
Average Volume	257,154.7x
Bv Per Share	0
CAPEX	$-21,000
Ch1m	-21.14
Ch1w	-4.9
Ch1y	-50.51
Ch3m	-23.02
Ch3y	51.54
Ch6m	-39.38
Change	1.17%
Change From Open	1.61
Close	0.96
Days Gap	-0.44
Depreciation Amortization	12,000
Dollar Volume	14,854.8
Earnings Date	2026-05-01
Earnings Time	amc
EBIT	$-21.1M
EBITDA	$-20.9M
EPS	$-0.16
F Score	1
FCF	$-12.9M
FCF EV Yield	-10.56x
FCF Per Share	$-0.1
Financing CF	10,006,000
Fiscal Year End	December
Founded	2,013
Investing CF	3,043,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-01
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-05-01
Ma150	1.33
Ma150ch	-26.96%
Ma20	1.1
Ma20ch	-11.82%
Net CF	286,000
Next Earnings Date	2027-04-30
Open	0.95
Optionable	Yes
Position In Range	27.8
Post Close	0.97
Postmarket Change Percent	-1.79
Postmarket Price	$0.95
Ppne	499,000
Pre Close	0.96
Price Date	2026-07-30
Ptbv Ratio	2,412.1
Relative Volume	0.06x
Share Based Comp	4,542,000
Tr6m	-39.38%
Volume	15,314.3

Tiziana Life Sciences Ltd (TLSA)

Coverage state: Market snapshot only — no published research

Generate the first TLSA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TLSA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TLSA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TLSA

Frequently asked questions